Overview

A Study to Assess the Long-term Safety and Efficacy of ASP1941 in Japanese Diabetic Patients

Status:
Completed
Trial end date:
2011-07-22
Target enrollment:
Participant gender:
Summary
The primary objective of this study is to evaluate the long-term safety of ASP1941 in patients with type 2 diabetes mellitus. The second objectives are to compare the efficacy and pharmacokinetics of ASP1941 administered before or after food intake.
Phase:
Phase 3
Details
Lead Sponsor:
Astellas Pharma Inc
Treatments:
Ipragliflozin